This compound is a quinazoline derivative that serves as a pharmaceutical impurity or intermediate in the synthesis of active pharmaceutical ingredients. Its structure features multiple functional groups including amine, ether, and aromatic rings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ethyl 4-{3-[2-(dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl}benzoate
pharmaceutical intermediate
N-[(1R,2R)-2-Amino-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzene-1-sulfonamide
pharmaceutical intermediate
2-Bromo-5-(trifluoromethyl)benzaldehyde
pharmaceutical intermediate
Bis(2-cyanoethyl)-N,N-diisopropyl phosphoramidite
pharmaceutical intermediate
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]formamide
FWNCTLUUKXETML-UHFFFAOYSA-N
CN(CCCNC=O)C1=NC2=CC(=C(C=C2C(=N1)N)OC)OC
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.